Medivation (MDVN) – StreetInsider.com Reports
-
Maverick Capital 13F Shows New Stakes in Blue Buffalo Pet (BUFF), Dollar General (DG), Increase in ABI (BUD), Philip Morris (PM), (More...)
-
Eton Park Capital's 13F Shows New Stakes Twitter (TWTR), Kinder Morgan (KMI), Whitewave (WWAV), Increase in Microsoft (MSFT) (More...)
-
Starboard Value Enters HPE (HPE), Raises Marvell (MRVL), Advanced Auto Parts (AAP) (more...) - 13F
-
Astellas Announces Presentation of Additional Positive XTANDI Data at ESMO 2016 (MDVN)
-
Pfizer (PFE) Closes Medivation (MDVN) Acquisition
-
Pfizer (PFE) Says HSR Act Waiting Period in Medivation (MDVN) Acquisition has Expired
-
Medivation (MDVN), Pfizer (PFE) File Premerger Notification with FTC
-
Medivation (MDVN) Bidding War Was Even Hotter Than the Market Thought
-
Top 10 News for 8/22 - 8/26: Yellen Hints at Hike; Muddy Waters Picks New Target; Pfizer, Medivation/Pfizer Make it Official
-
Maxim Group Downgrades Medivation (MDVN) to Hold Amid Takeover
-
Stifel Downgrades Medivation (MDVN) to Hold
-
Barclays Downgrades Medivation (MDVN) to Equalweight
-
Credit Suisse Downgrades Medivation (MDVN) to Neutral; Sees Little Likelihood of Competing Bid
-
SunTrust Downgrades Medivation (MDVN) to Neutral
-
Citi Downgrades Medivation (MDVN) to Neutral
-
Moody's Affirms Ratings on Pfizer (PFE) Amid Move to Acquire Medivation (MDVN); Outlook Remains Negative
-
Brean Capital Downgrades Medivation (MDVN) to Hold
-
Wedbush Downgrades Medivation (MDVN) to Neutral
-
Unusual 11 Mid-Day Movers 8/22: (RLJE) (CIFC) (CYCC) Higher; (DRD) (PRTS) (XTNT) Lower
-
BMO 'Neutral to Positive' on Pfizer's (PFE) Medivation Takeover
-
Barclays Downgrades Medivation (MDVN) to Equalweight
-
Notable Mergers and Acquisitions 8/22: (PFE)/(MDVN) (CST) (CIFC) (MOBI)
-
Vertex (VRTX), BioMarin (BMRN), Intercept (ICPT), Others Highlighted as Targets at BMO Following PFE/MDVN
-
Pre-Open Stock Movers 08/22: (CIFC) (ISIL) (MDVN) Higher; (STRP) (MRO) (WDAY) Lower (more...)
-
Wall St. little changed as biotechs offset energy drop
-
BioMarin Pharma (BMRN) Trades Higher After Pfizer (PFE) Wins Medivation (MDVN) (SNY)
-
Pfizer (PFE) to Acquire Medivation (MDVN) in $14B Deal
-
Stocks with Implied Volatility Movement
-
Pfizer (PFE) Near Deal to Acquire Medivation (MDVN) for $14 Billion
-
Stocks with Implied Volatility Movement
-
Medivation (MDVN) September calls active following Reuters report
-
UPDATE: Merck (MRK) Enters Race for Medivation (MDVN) - Reuters
-
Maverick Capital's 13F Shows New Stakes in Computer Sciences (CSC), Level 3 (LVLT), Philip Morris (PM), Increase in Comcast (CMCSA), Gilead (GILD) (More...)
-
Eton Park Capital's 13F Shows New Stakes in Alibaba (BABA), Barclays (BCS), Medivation (MDVN), Increase in Microsoft (MSFT) (More...)
-
Halvorsen's Viking Global Boosts Facebook (FB), Alibaba (BABA) Stakes in Q2; Exits Pfizer (PFE), Home Depot (HD) - 13F
-
Stocks with Implied Volatility Movement
-
Stocks with Implied Volatility Movement
-
Sanofi (SNY) and Pfizer (PFE) Face Competition from German Bidder in Struggle for Medivation (MDVN) - Source
-
Medivation (MDVN): Anemic Growth from Xtandi - Jefferies
-
JMP Securities Downgrades Medivation (MDVN) to Market Perform
-
Medivation (MDVN) PT Lifted to $53 at BMO Capital
-
Medivation (MDVN) Tops Q2 EPS by 2c, Affirms Guidance
-
Trading Radar for 8/9: Disney (DIS), Coach (COH), Valeant Pharma (VRX), Wayfair (W), Yelp (YELP) Report
-
CVS, Express Scripts 2017 Formulary Exclusion Lists Make Waves
-
CVS Health (CVS) to Exclude Medivation's (MDVN) Xtandi in 2017 Main Formulary - Bloomberg
-
Medivation (MDVN) Notes 11% Increase in Q2 U.S. XTANDI Sales; FY16 Outlook Reaffirmed
-
UPDATE: Medivation (MDVN) said to ask for buyer interest by mid-August - CNBC (GILD) (SNY)
-
Streetinsider.com's Hot Lunchtime Reads 7/27: (MDVN) (JNPR) (LH) (AMAT)
-
Medivation (MDVN) Cancelled Bus Tour Has Rumor Mill Buzzing
-
Pfizer (PFE) Set to Make Rival Bid for Medivation (MDVN) - Source
Back to MDVN Stock Lookup